Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.35
+0.05 (0.17%)
Apr 29, 2026, 1:30 PM CST
0.06%
Market Cap 1.76B
Revenue (ttm) 1.38B
Net Income (ttm) 164.28M
Shares Out 59.83M
EPS (ttm) 2.72
PE Ratio 10.79
Forward PE n/a
Dividend 0.95 (3.25%)
Ex-Dividend Date Aug 26, 2025
Volume 75,648
Average Volume 86,092
Open 29.25
Previous Close 29.30
Day's Range 29.25 - 29.35
52-Week Range 28.24 - 32.90
Beta 0.22
RSI 49.38
Earnings Date Mar 13, 2026

About TPEX:4111

Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and... [Read more]

Sector Healthcare
Founded 1962
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4111
Full Company Profile

Financial Performance

In 2025, TPEX:4111's revenue was 1.38 billion, an increase of 18.11% compared to the previous year's 1.17 billion. Earnings were 164.28 million, an increase of 48.49%.

Financial Statements

News

There is no news available yet.